Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis
Latest Information Update: 01 Oct 2012
At a glance
- Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors LETI Pharma GmbH
- 01 Oct 2012 New trial record